Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
about
Advances and Challenges in Studying Hepatitis B Virus In VitroHepatitis B virus therapy: What's the future holding for us?Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Anti-HBV Drugs: Progress, Unmet Needs, and New HopeTherapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckCurrent and future directions for treating hepatitis B virus infectionMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsHepatitis B: future curative strategiesThe Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunitySuppression of APOBEC3-mediated restriction of HIV-1 by VifIntrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis BCell Culture Models for the Investigation of Hepatitis B and D Virus InfectionHepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protectionRoles of hepatocyte nuclear factors in hepatitis B virus infectionFuture Therapy for Hepatitis B Virus: Role of ImmunomodulatorsAPOBEC3 Interference during Replication of Viral GenomesNovel therapeutic approaches for hepatitis B virus covalently closed circular DNADisease-promoting effects of type I interferons in viral, bacterial, and coinfectionsMolecular biology of hepatitis B virus infectionCurrent and future antiviral drug therapies of hepatitis B chronic infectionTGF-β triggers HBV cccDNA degradation through AID-dependent deaminationDNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B VirusAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.The Role of cccDNA in HBV Maintenance.Detection of HBV Covalently Closed Circular DNASustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis BHepatitis B Virus Immunopathology, Model Systems, and Current TherapiesSustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksBoth interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Strategies to eliminate HBV infection.Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infectionInvolvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B virusesCRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusHepatitis B virus: new therapeutic perspectives.APOBEC4 Enhances the Replication of HIV-1.
P2860
Q26771134-5373C5AB-DECD-4C92-9F41-0712C7D71CA4Q26774198-39F65A1D-E6DC-418F-A40E-F8F3CCBCD432Q26781812-C3CD123B-1742-4176-8DA0-D0BD2DC194A1Q26782742-E2AE6935-F08E-4C08-9807-A35CC985EDEEQ26828598-C129C217-A5A5-44FE-9473-196A9929D799Q26851240-D7E4F1F5-8777-42AF-88D2-A0736D94A888Q27002598-4A61C177-ACEB-4A93-9B1A-BD3395DF1DBFQ27011623-8E4E837F-37FC-4C23-A87B-418968F9FF9DQ27025082-410760CA-38F3-4DF3-8662-5C4589ADE8C9Q27025150-EC4B65EE-42DA-421E-9AF4-4AD1344C890CQ27318089-583EF662-967D-43B5-A45C-BD8EE4801293Q28068209-A3F0CA20-CF5A-47E7-AB5C-2AAD08D1DC21Q28069273-1776C0E4-8FDE-46C2-9B38-08A0255B117CQ28069574-346B6E83-406D-4614-BFF3-4A62DB8331ABQ28078148-50FB721A-E8EC-4B05-8BC7-67CBB06A11D5Q28081195-6419AB00-304E-4610-9BC8-4E270A7C13FCQ28081274-8913ADD0-31A6-409C-ABC2-3E1D570FB557Q28082841-49082E15-5A57-4BA8-AD9B-6FFE41F29DA3Q28083478-08F63C8D-4DCF-468C-919B-957142C00B77Q28084820-8B4CA325-AC41-40C1-A67A-AE36A321EBC2Q28119132-907E924A-540E-4AC1-A330-0BA11C025B9DQ28552967-BAE9E959-F0BD-4B2C-B1EE-477BDA51A9C9Q30391932-60C44270-D158-4B5B-AE44-C367FF6B6391Q30853937-1CD86006-4527-4E2B-8648-4540C69D75C9Q30854409-991ED491-BEBB-4AED-8A8A-06D6F442EE44Q32182914-75230305-84D6-4CD7-A149-5297397983EBQ32183310-C78657A7-427C-4A97-A1AF-6FA9FB3FB5ACQ33419607-4D226E80-5F96-4038-80E9-E09A75266CD6Q33559657-EA2A929F-D138-4B55-859C-13644AAD0EF8Q33635361-9580BFE9-938A-410D-A3DA-1151F27B6BB5Q33753902-780E1F71-C929-40EB-AACF-CBB912CD0001Q33807794-13E401FD-8BC2-4082-87E8-816CACE66F19Q34082747-2E768031-54D0-43C5-BAA7-743005F47BA9Q34289969-9C14C886-6933-4C3E-9013-B3E6C7DD5BD8Q34308129-8B9791B0-F5E2-4BEB-9754-28D76052ECE5Q34388160-F7A281EF-633B-4544-BB34-C86643485022Q34407460-159F7AF3-33F3-46D9-A572-2B2F69C15AB5Q34478938-D3AE44E3-1959-476D-AE55-6E8BB87F643AQ34507250-6EC454AE-0087-4006-9D60-419DF06D10C0Q34529142-C07AD7CF-66D4-4E10-BD46-C638E1E4BAA1
P2860
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@en
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@nl
type
label
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@en
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@nl
prefLabel
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@en
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
@nl
P2093
P2860
P50
P356
P1433
P1476
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA
@en
P2093
Caroline Remouchamps
Carsten Münk
Daniela Stadler
Emmanuel Dejardin
Florian Reisinger
Herwig Koppensteiner
Jeffrey L Browning
Martin F Sprinzl
Mathias Heikenwalder
P2860
P304
P356
10.1126/SCIENCE.1243462
P407
P577
2014-02-20T00:00:00Z